Attention: Purchased AACR Annual Meeting 2013 webcasts? Your login information was emailed to you on May 1, 2013.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

    clear all | select all

    Conferences:

    Availability:

    clear all | select all

    Participation Type:

    Presentations Access:

    • — purchase

    Presentation Access:

    clear all | select all

    Topic Tracks*:

    clear all | select all

    Organ Site Tracks*:

    *Topic Tracks and Organ Site Tracks are assigned to the entire session. Therefore, if one presentation in a session is assigned to a particular track, all presentations in the session would be returned in the search results.
    • Sort by:
    • Browse by:
    << first | < prev next > | last >>
    presentations: 1 to 25 of 4689
    page: of 188 records per page:
    Opening Ceremony
    Opening Remarks
    Margaret Foti
    American Association for Cancer Research, Philadelphia, PA
    President's Remarks
    Frank McCormick
    UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States
    from AACR Annual Meeting 2013 on April 7, 2013 8:30 AM-9:40 AM
    Seventh Annual AACR Team Science Award
    Team Science Award Presentation
    The Johns Hopkins Pancreatic Cancer Sequencing Team
    Johns Hopkins University School of Medicine, Baltimore, MD, United States
    from AACR Annual Meeting 2013 on April 7, 2013 8:30 AM-9:40 AM
    Tenth Annual AACR Award for Lifetime Achievement in Cancer Research
    Award Recipient
    Harold L Moses
    Vanderbilt-Ingram Cancer Center, Nashville, TN, United States
    from AACR Annual Meeting 2013 on April 7, 2013 8:30 AM-9:40 AM
    In Memoriam: Zora Brown
    Margaret Foti
    American Association for Cancer Research, Philadelphia, PA
    from AACR Annual Meeting 2013 on April 7, 2013 8:30 AM-9:40 AM
    Introduction of the Fellows of the AACR Academy
    Charles L. Sawyers
    Memorial Sloan-Kettering Cancer Center, New York, NY, United States
    from AACR Annual Meeting 2013 on April 7, 2013 8:30 AM-9:40 AM
    In Memoriam: Jane Cooke-Wright
    Marcia R. Cruz-Correa
    University of Puerto Rico Comprehensive Cancer Center
    from AACR Annual Meeting 2013 on April 7, 2013 8:30 AM-9:40 AM
    Seventh Annual AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
    Award Recipient
    Robert C Young
    RCY Medicine, Philadelphia, PA, United States
    from AACR Annual Meeting 2013 on April 7, 2013 8:30 AM-9:40 AM
    2013 AACR Distinguished Public Service Award
    Introduction
    Frank McCormick
    UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States
    Award Recipient
    Katie Couric
    Cancer Advocate, Host of "Katie," and Award-Winning Journalist
    from AACR Annual Meeting 2013 on April 7, 2013 8:30 AM-9:40 AM
    From Discovery Science to Precision Medicine: Paving the Path to Progress
    From genes to microenvironments: Cancer as an “organismal” disease
    Siddhartha Mukherjee
    Columbia University, New York, NY, United States
    •  
    • Permission not
      granted for presentation
    •  
    •  
    from AACR Annual Meeting 2013 on April 7, 2013 9:40 AM-12:00 PM
    From Discovery Science to Precision Medicine: Paving the Path to Progress
    Immune checkpoint blockade: Unleashing the immune system against cancer
    Suzanne L Topalian
    Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
    •  
    • Permission not
      granted for presentation
    •  
    •  
    from AACR Annual Meeting 2013 on April 7, 2013 9:40 AM-12:00 PM
    From Discovery Science to Precision Medicine: Paving the Path to Progress
    The therapeutic implications of genome sequencing and expression analyses for breast cancer
    Charles M Perou
    Univ. of North Carolina at Chapel Hill, Chapel Hill, NC, United States
    from AACR Annual Meeting 2013 on April 7, 2013 9:40 AM-12:00 PM
    From Discovery Science to Precision Medicine: Paving the Path to Progress
    Wnt signaling, Lgr5 stem cells, and cancer
    Hans Clevers
    Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences & University Medical Centre Utrecht, Utrecht, Netherlands
    from AACR Annual Meeting 2013 on April 7, 2013 9:40 AM-12:00 PM
    Biomarkers and Clinical Targeting of the PI3 Kinase and VEGF Pathways
    Relationship between tumor biomarkers (BM) and efficacy in EMILIA, a phase III study of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC)
    José Baselga
    Mass. General Hospital Cancer Center Administration, Boston, MA, United States
    •  
    • Free
    • Unknown permission
      for presentation
    •  
    •  
    from AACR Annual Meeting 2013 on April 7, 2013 3:00 PM-5:30 PM
    Biomarkers and Clinical Targeting of the PI3 Kinase and VEGF Pathways
    Discussant
    Gordon B Mills
    UT MD Anderson Cancer Ctr., Houston, TX, United States
    from AACR Annual Meeting 2013 on April 7, 2013 3:00 PM-5:30 PM
    Biomarkers and Clinical Targeting of the PI3 Kinase and VEGF Pathways
    Results of two phase I multicenter trials of AZD5363, an inhibitor of AKT1, 2 and 3: Biomarker and early clinical evaluation in Western and Japanese patients with advanced solid tumors
    Udai Banerji
    Inst. of Cancer Research, Sutton, United Kingdom
    from AACR Annual Meeting 2013 on April 7, 2013 3:00 PM-5:30 PM
    Biomarkers and Clinical Targeting of the PI3 Kinase and VEGF Pathways
    Discussant
    Carlos L Arteaga
    Vanderbilt-Ingram Cancer Ctr., Nashville, TN, United States
    from AACR Annual Meeting 2013 on April 7, 2013 3:00 PM-5:30 PM
    Biomarkers and Clinical Targeting of the PI3 Kinase and VEGF Pathways
    Towards defining the genetic framework for clinical response to treatment with BYL719, a PI3Kalpha-specific inhibitor
    Jordi Rodon
    Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain
    from AACR Annual Meeting 2013 on April 7, 2013 3:00 PM-5:30 PM
    Biomarkers and Clinical Targeting of the PI3 Kinase and VEGF Pathways
    Discussant
    Lewis C. Cantley
    Weill Cornell Medical College, New York, NY, United States
    from AACR Annual Meeting 2013 on April 7, 2013 3:00 PM-5:30 PM
    Biomarkers and Clinical Targeting of the PI3 Kinase and VEGF Pathways
    GDC-0032, a beta isoform-sparing PI3K inhibitor: Results of a first-in-human phase Ia dose escalation study
    Dejan Juric
    Massachusetts General Hospital Cancer Center, Boston, MA, United States
    •  
    • Free
    • Unknown permission
      for presentation
    •  
    •  
    from AACR Annual Meeting 2013 on April 7, 2013 3:00 PM-5:30 PM
    Biomarkers and Clinical Targeting of the PI3 Kinase and VEGF Pathways
    Discussant
    Sarat Chandarlapaty
    Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
    from AACR Annual Meeting 2013 on April 7, 2013 3:00 PM-5:30 PM
    Biomarkers and Clinical Targeting of the PI3 Kinase and VEGF Pathways
    REGARD: A phase III, randomized, double-blind trial of ramucirumab and best supportive care (BSC) versus placebo and BSC in the treatment of metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line platinum- and/or fluoropyrimidine-containing combination therapy
    Charles S Fuchs
    Dana-Farber Cancer Inst., Boston, MA, United States
    from AACR Annual Meeting 2013 on April 7, 2013 3:00 PM-5:30 PM
    Biomarkers and Clinical Targeting of the PI3 Kinase and VEGF Pathways
    Discussant
    Herbert I Hurwitz
    Duke Univ. Medical Ctr., Durham, NC, United States
    from AACR Annual Meeting 2013 on April 7, 2013 3:00 PM-5:30 PM
    Stand Up To Cancer Press Event
    Margaret Foti, Ph.D., M.D. (h.c.)
    Chief executive officer, American Association for Cancer Research
    Kyle MacLachlan
    SU2C Celebrity Ambassador
    Phillip Sharp, Ph.D.
    SU2C Scientific Advisory Committee chairperson, institute professor David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
    William G. Nelson, M.D., Ph.D.
    SU2C Scientific Advisory Committee vice-chairperson; director, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
    Kathleen Ruddy
    Chief executive officer, St. Baldrick's Foundation
    John M. Maris, M.D.
    Director, the Center for Childhood Cancer Research, The Children’s Hospital of Philadelphia
    Crystal L. Mackall, M.D.
    Chief, Pediatric Oncology Branch, National Cancer Institute
    Kari and Tom Whitehead
    Parents of Emily Whitehead
    Emily Whitehead
    Cancer patient
    from AACR Annual Meeting 2013 on April 7, 2013 5:00 PM-6:00 PM
    Epigenetic Targets for Cancer
    Cancer genetic and epigenetic interactions
    Peter W Laird
    USC Epigenome Center, Los Angeles, CA, United States
    from AACR Annual Meeting 2013 on April 8, 2013 8:00 AM-10:00 AM
    Epigenetic Targets for Cancer
    TET proteins and altered DNA methylation in cancer
    Anjana Rao
    La Jolla Inst. for Allergy & Immunology, La Jolla, CA, United States
    •  
    • Permission not
      granted for presentation
    •  
    •  
    from AACR Annual Meeting 2013 on April 8, 2013 8:00 AM-10:00 AM
    << first | < prev next > | last >>
    presentations: 1 to 25 of 4689
    page: of 188 records per page: